FindTrial
Sign In

A Study Comparing Two Nasal Sprays (Mometasone and Fluticasone) in Children with Enlarged Adenoids to See Which Works Better

Comparative efficacy of Mometasone Furoate versus Fluticasone Fumarate Nasal Spray Using Clinical and Radiological Scoring in Children with Adenoid Hypertrophy - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/07/090164
Enrollment
60
Registered
2025-07-03
Start date
Unknown
Completion date
Unknown
Last updated
2026-06-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J352- Hypertrophy of adenoids

Interventions

Intervention1: Mometasone Furoate Nasal Spray: Comparing the efficacy of Mometasone furoate intranasal corticosteroid versus Fluticasone furoate intranasal corticosteroid nasal spray before and aft

Sponsors

VANDANAPU VENKATA SRI HARSHA
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Children aged between 2 and 14 years who are newly diagnosed with adenoid hypertrophy, exhibiting symptoms such as snoring, mouth-breathing and obstructive breathing during sleep, and confirmed by lateral neck radiography, will be included in the study.

Exclusion criteria

Exclusion criteria: Immunocompromised patients, nasal structural disease, prior tonsil or adenoid surgery, craniofacial abnormalities

Design outcomes

Primary

MeasureTime frame
Identification of the most effective intranasal corticosteroid for improving symptoms and reducing adenoid size in children with adenoid hypertrophy. Insights into the optimal choice of intranasal corticosteroid based on clinical and radiological considerations. Timepoint: 3 months—

Secondary

MeasureTime frame
NILTimepoint: NIL—

Countries

India

Contacts

Public ContactDR R PRASANNA RAJU

SRM MEDICAL COLLEGE HOSPITAL AND RESEARCH CENTER

Dr_prasannaraju@yahoo.com9841114613

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Jun 29, 2026